Atıf Formatları
Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. KARAKOYUN ÇELİK Et Al. , "Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer," ESTRO 2023 , VIYANA, Austria, 2023

KARAKOYUN ÇELİK, Ö. Et Al. 2023. Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer. ESTRO 2023 , (VIYANA, Austria).

KARAKOYUN ÇELİK, Ö., Uncu, O., & Ayaydın, B., (2023). Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer . ESTRO 2023, VIYANA, Austria

KARAKOYUN ÇELİK, ÖMÜR, Osman Uncu, And Büşra Ayaydın. "Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer," ESTRO 2023, VIYANA, Austria, 2023

KARAKOYUN ÇELİK, ÖMÜR K. Et Al. "Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer." ESTRO 2023 , VIYANA, Austria, 2023

KARAKOYUN ÇELİK, Ö. Uncu, O. And Ayaydın, B. (2023) . "Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer." ESTRO 2023 , VIYANA, Austria.

@conferencepaper{conferencepaper, author={ÖMÜR KARAKOYUN ÇELİK Et Al. }, title={Chemoradiotherapy induced hypomagnesemia is associated with superior survival in laryngeal cancer}, congress name={ESTRO 2023}, city={VIYANA}, country={Austria}, year={2023}}